Massage & Cold Water Immersion on Movement Variability an Muscle Tone of

Status Not yet recruiting

Clinical Trial Summary

Training prescription is planned considering recovery periods to enhance performance. To assess recovery, a complexity model can be used, in which the main variable would correspond to a fractal of performance. To assess the effectiveness of post-exercise massage and cold-water immersion under a new prism of recovery by means of muscle stiffness and movement variability analysis regarding the sport-specific gesture and an experimental task of shoulder elevation in swimmers.

Clinical Trial Description

Fifty swimmers from São Paulo state swimming teams will be initially assessed to investigate movement patterns at rest and after a fatigue protocol by means of inertial sensors. The participants will be assessed regarding their perceptions by the Swimmer's Perception of Effort Questionnaire (SPEQ), muscle stiffness by a myotonometer, skin temperature by a thermographic infrared camera and coordination by the Coordination Index and Continuous Relative Phase (CRP). Then, the athletes will perform the fatigue protocol again followed by five interventions in a crossover design separated by 24hr: i) superficial massage, ii) deep massage iii) cold-water immersion iv) immersion in thermoneutral water and v) control (no intervention). All procedures will be performed for an experimental task of shoulder elevation and the sport-specific gesture (front crawl simulation in swim bench). The statistical analysis will be conducted in SPSS software. To analyze fractal properties of time series the detrended fluctuation analysis (DFA) will be used where (α) varies from 0,5 to 1,5, interpreted as random series and Brownian noise, respectively. To compared pre and post assessments from initial testing the paired t test will be used. To compare perceptions, muscle stiffness and temperature between groups after fatigue protocol and intervention a Mixed ANOVA will be used with Greenhouse-Geisser corrections and Bonferroni post-hoc if necessary. Descriptive data will be presented as mean and standard deviations. All analysis will assume level of significance of P< 0,05. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04541901
Study type	Interventional
Source	São Paulo State University
Contact	Flavia A Carvalho, Master
Phone	18997446324
Email	fla.acarvalho@hotmail.com
Status	Not yet recruiting
Phase	N/A
Start date	March 20, 2023
Completion date	September 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05623644` - Multimodal MR Imaging Study on ET and PD Patients Subjected With MRgFUS Thalamotomy
Active, not recruiting	`NCT03548779` - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2	N/A
Completed	`NCT03295786` - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease	Phase 1/Phase 2
Completed	`NCT03722212` - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test	N/A
Recruiting	`NCT05973929` - Movement Disorders in Multiple Sclerosis Patients
Terminated	`NCT02823158` - Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM	N/A
Enrolling by invitation	`NCT01210781` - Target Planning for Placement of DBS-electrodes and Follow-up of the Clinical Efficacy of Stimulation
Enrolling by invitation	`NCT00355927` - Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.	N/A
Completed	`NCT00037167` - Effects of Exercise Poles on Older Adults During Exercise Walking	Phase 1/Phase 2
Recruiting	`NCT04784494` - MST for Parkinson's Disease	N/A
Terminated	`NCT03270189` - Effect of the Visual Information Change in Functional Dystonia	N/A
Recruiting	`NCT04061135` - Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders	N/A
Recruiting	`NCT04176692` - The Effects of Muscle Characteristics on the Control of Shoulder Complex During Functional Movements
Suspended	`NCT04912115` - Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia	Phase 2
Completed	`NCT00500994` - Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures	Early Phase 1
Completed	`NCT04536987` - Robot Therapy for Rehabilitation of Hand Movement After Stroke	Phase 2
Recruiting	`NCT00001208` - Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Completed	`NCT02392078` - Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Completed	`NCT00552474` - Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease	N/A
Not yet recruiting	`NCT05032911` - Sensorimotor Control in People With and Without Neck Pain

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Massage and Cold Water Immersion on Movement Variability an Muscle Tone of Swimmers

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms